查詢結果分析
來源資料
相關文獻
- Pre-Anesthetic Oral Clonidine is Effective to Prevent Post-Spinal Shivering
- 評估肌肉內注射Meperidine對預防脊髓麻醉顫抖之效果
- Low Dose Ketamine and Midazolam as Supplements for Spinal Anesthesia
- Isobaric Spinal Anesthesia for Paraplegic Patients
- Prevention of Hypotension after Spinal Anesthesia for Cesarean Section: Dextran 40 Versus Lactated Ringer's Solution
- Spinal Anesthesia for Cesarean Section: Isobaric Versus Hyperbaric Solution
- 家族遺傳性顫抖與陷窩梗塞伴隨老年失智之病例報告
- Postoperative Pain Relief in Primigravida Caesarean Section Patients--Combination of Intrathecal Morphine and Epinephrine
- Anesthesia and Postoperative Shivering: Its Etiology, Treatment and Prevention
- Dopamine Deficiency in Rubral Tremor Caused by Midbrain Hemangioma: Case Report
頁籤選單縮合
題 名 | Pre-Anesthetic Oral Clonidine is Effective to Prevent Post-Spinal Shivering=口服Clonidine可以有效預防脊髓麻醉後之顫抖 |
---|---|
作 者 | 毛志傑; 鄒美勇; 賈元一; 鄒樂起; 陳國瀚; 李德譽; | 書刊名 | 麻醉學雜誌 |
卷 期 | 36:3 1998.09[民87.09] |
頁 次 | 頁137-142 |
分類號 | 416.54 |
關鍵詞 | 脊髓麻醉; 顫抖; 核心溫度; 耳鼓膜; Clonidine; Anesthesia; Spinal; Shivering; Body temperature; Core; Tympanic membrane; |
語 文 | 英文(English) |
中文摘要 | 背景:脊髓麻醉常伴隨顫抖現象,吾人之處置多為治療,而非預防。本研究於脊 髓麻醉前給予病人口服clonidine,評估其預防顫抖之效力。 方法:本研究選擇100名40歲以上,美國麻醉醫學會體位分級一至三級,準備以脊髓 麻醉施行泌尿道手術之男性病患。病患於脊髓麻醉前90分鐘隨機分為clonidine組(n=48) 及控制組(n=52),分別口服clonidine 150μg及安慰劑,並以雙盲法進行研究。脊髓麻醉以 bupivacaine阻斷至胸椎第十節左右。然後觀察病患的顫抖程度,並於脊髓麻醉後30分鐘記 錄耳鼓膜溫度。定量結果以平均值±標準差,定性結果以百分比表示。統計採Chi-square, 及Student's t-test。P值小於0.05視為有統計意義。 結果:脊髓麻醉後的顫抖比例,Clonidine組比控制組的發生率低及程度較輕微(依顫 抖分級:無、輕度、中度、重度),在脊髓麻醉後30分鐘內觀察,結果分別是83%比42%, 10%比6%,10比19%,0%比33%,p<0.05。此時耳鼓膜溫度,Clonidine組與控制組比較 為35.9±0.8℃比35.9±0.7℃,並無顯著差異。 結論:脊髓麻醉前給予病人口服clonidine 150μg,可以有效預防脊髓麻醉後的顫抖。 |
英文摘要 | Background:Shivering is a common event during spinal anesthesia. Customarily we just treat it rather than prevent it. This study was designed to evaluate the efficacy of oral clonidine as a premedication to prevent post-spinal shivering. Methods:One hundred males of ASA physical status I-III, aged above 40, scheduled for elective urological surgery under spinal anesthesia, were included in this study. All participants were randomly divided into the clonidine and control groups. They received either oral clonidine 150μ g(n=48) or placebo(n=52) 90 min before spinal anesthesia in a double-blind fashion. Spinal blockade was induced with heavy bupivacaine to a dermatomal level near T□. The shivering was graded as:none, no perceptible tension of muscles observed; mild, slight muscle tonus(masseter muscle); moderate, real shivering(proximal muscles); and severe, generalized shivering(whole body). The tympanic membrane temperature was recorded 30 min after spinal anesthesia. Data were expressed as means ±standard deviation. Chi-square and Student's t-test were used. A p value less than 0.05 was considered statistically significant. Results:The incidence of post-spinal shivering, which was graded as none, mild, moderate, and severe, showed statistically significant differences(p<0.05) between clonidine 150μg and placebo(83% vs.42%, 10%vs.6%, 10%vs.19%, 0%vs.33%, respectively)during the 30 min immediately after spinal anesthesia. The respective mean tympanic temperature in oral clonidine and placebo groups showed no difference (clonidine vs. control=35.9±0.8℃vs.35.9±0.7℃). Conclusions:Pre-anesthetic medication with oral clonidine 150μg is effective to prevent post- spinal shivering in patients undergoing elective urological surgery. |
本系統中英文摘要資訊取自各篇刊載內容。